CoreCap Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$708K Buy
12,114
+5,359
+79% +$299K 0.02% 469
2026
Q2
$368K Buy
6,755
+3,670
+119% +$179K 0.01% 652
2026
Q1
$132K Buy
3,085
+3,082
+102,733% +$133K ﹤0.01% 940
2025
Q4
$131 Sell
3
-3,318
-100% -$137K ﹤0.01% 2853
2025
Q3
$137K Sell
3,321
-11,723
-78% -$471K 0.01% 923
2025
Q2
$663K Sell
15,044
-4,025
-21% -$161K 0.03% 437
2025
Q1
$704K Buy
+19,069
New +$679K 0.03% 408
2022
Q4
$8.02K Buy
+500
New +$8.15K ﹤0.01% 1609
2022
Q3
– Sell
-500
Closed -$10K – 1011
2022
Q2
$10K Buy
+500
New +$10.3K ﹤0.01% 1475
2022
Q1
– Sell
-500
Closed -$9K – 1018
2021
Q4
$9K Buy
+500
New +$9.6K ﹤0.01% 1579

Other funds holding EXEL

CoreCap Advisors's EXEL Position: Q3 2026 in Review

CoreCap Advisors increased its Exelixis (EXEL) stake by 79% in Q3 2026, buying an estimated $299K and bringing the position to 12,114 shares worth $708K. The position accounts for 0.02% of the portfolio, ranked #469.

CoreCap Advisors first reported a position in EXEL in Q4 2021 and has held it in 10 quarters since. 145 funds tracked by Wall St. Rank hold EXEL as of Q3 2026.

  • CoreCap Advisors held 12,114 shares of Exelixis worth $708K as of Q3 2026.
  • CoreCap Advisors bought 5,359 Exelixis shares in Q3 2026, an estimated $299K.
  • Exelixis made up 0.02% of CoreCap Advisors's portfolio in Q3 2026, its #469 holding.
  • CoreCap Advisors first reported a position in Exelixis in Q4 2021 and has held it in 10 quarters since.
  • 145 funds tracked by Wall St. Rank held Exelixis as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.